Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evolut PRO China Clinical Study
Sponsor: Medtronic Cardiovascular
Summary
Interventional study to evaluate the safety and efficacy of the Medtronic CoreValve™ Evolut™ PRO System when used by China implanting centers in Chinese patients with severe symptomatic aortic stenosis (AS) who are at high risk for Surgical Aortic Valve Replacement (SAVR).
Official title: Medtronic CoreValve™ Evolut™ PRO System China Clinical Study
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2021-07-17
Completion Date
2028-05-15
Last Updated
2025-12-03
Healthy Volunteers
No
Conditions
Interventions
Medtronic CoreValve™ Evolut™ PRO System
The system comprised of the following three components: 1. CoreValve™ Evolut™ PRO Transcatheter Aortic Valve (TAV) 2. EnVeo™ PRO Delivery Catheter System (DCS) 3. EnVeo™ PRO Loading System (LS)
Locations (4)
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Chinese PLA General Hospital, Chinese PLA Medical School
Beijing, Beijing Municipality, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China